124 related articles for article (PubMed ID: 17671706)
1. Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.
Jung JJ; Jeung HC; Lee JO; Kim TS; Chung HC; Rha SY
Oncol Rep; 2007 Sep; 18(3):593-9. PubMed ID: 17671706
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D; Le Morvan V; Bonnet J; Robert J
Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
6. [Differences in gene expression profile between high and low metastatic human colorectal cancer cell lines].
Weng DS; Ding YQ; Sun Q
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):256-9. PubMed ID: 15041535
[TBL] [Abstract][Full Text] [Related]
7. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Noguchi T; Kawahara K; Natsugoe S; Aikou T; Okazaki Y; Hayashizaki Y; Sato Y; Todo S; Hiyama E; Nishiyama M
Int J Oncol; 2006 May; 28(5):1153-62. PubMed ID: 16596231
[TBL] [Abstract][Full Text] [Related]
9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
10. Analysis of progressively overexpressed genes in tumorigenesis of colorectal cancers using cDNA microarray.
Wang JY; Yeh CS; Tzou WS; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Lin SR
Oncol Rep; 2005 Jul; 14(1):65-72. PubMed ID: 15944769
[TBL] [Abstract][Full Text] [Related]
11. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
[TBL] [Abstract][Full Text] [Related]
13. [Screening of differentially expressed genes related to laterally spreading tumor by cDNA microarray].
Wang XY; Jiang B; Lai ZS; Ma WM; Geng Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1023-5. PubMed ID: 15447852
[TBL] [Abstract][Full Text] [Related]
14. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
Samimi G; Manorek G; Castel R; Breaux JK; Cheng TC; Berry CC; Los G; Howell SB
Cancer Chemother Pharmacol; 2005 Jan; 55(1):1-11. PubMed ID: 15378272
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of colorectal cancer: preoperative genetic diagnosis using endoscopic biopsies.
Komori T; Takemasa I; Yamasaki M; Motoori M; Kato T; Kikkawa N; Kawaguchi N; Ikeda M; Yamamoto H; Sekimoto M; Matsubara K; Matsuura N; Monden M
Int J Oncol; 2008 Feb; 32(2):367-75. PubMed ID: 18202759
[TBL] [Abstract][Full Text] [Related]
17. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
19. [Mining microarray gene expression data of metastatic colorectal cancer by literature profiling].
Huang ZX; Sun Q; Ding YQ; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1195-7. PubMed ID: 14625187
[TBL] [Abstract][Full Text] [Related]
20. [Study on radiation sensitivity of colorectal cancer cells using gene expression profile].
Yang XD; Xing CG; Gong W; Zhou LY; Wu YY; Zhao K
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):371-3. PubMed ID: 19598022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
